Benefit From The Power And Intelligence Of IQVIA IRT SAVE

As modern trials grow in complexity, so do challenges for sponsors. Ensuring that patients receive the right IP at the right time is critical and often leads to oversupply.

On average, sponsors oversupply IP sites by almost 200%. What if you could ensure that sites' drug supply and patient volumes are always aligned?

IQVIA IRT SAVE, our supply automation value engine, gives sites a better way to manage IP. They key is intelligent automation. Our proprietary algorithms analyze drug supply data and automatically adjust delivery quantities to each site based on data already available in IRT.